Preferred Drug List Review Panel

The Medicaid and Health Choice Preferred Drug List (PDL) Review Panel was established by DHHS to conduct open meetings to discuss recommended policies and procedures related to the PDL and to address the public comments that were received during the PDL comment period. The administration and review of the North Carolina Medicaid and Health Choice PDL follows the Preferred Drug List Review Panel Guidelines and Procedures.

To sign up to speak at the PDL Review Panel Meeting, send an email to  Please include the name of the speaker, the represented organization and the drug name.  You may attach any clinical information regarding the drug you wish the PDL Panel to review beforehand.  Presentations are allowed only in the drug classes with changes and should not exceed three minutes.

Review Panel Meeting

2020 PDL Panel Meeting 

July 15, 2020, 1- 6 p.m.


Meeting Archives


Recommendations and Reports

PDL Panel Members

Aug. 1, 2018 – July 31, 2020
Panel Member Position Organization
Blake Cook, R.Ph. Pharmacist Interim Pharmacy Director, Division of Health Benefits
Seung Kim, MD Physician Old North State Medical Society
Ann McGee, PharmD Pharmacist Hospital-Based Pharmacy
Janice Huff, MD, FAAFP PhysicianPhysician Community Care of North Carolina
Casey Johnson, PharmD Pharmacist N.C. Association of Pharmacists
Anna Miller-Fitzwater, MD Physician N.C. Pediatric Society
Theodore Zarzar, MD Physician N.C. Psychiatric Association
Duncan Vincent, MD, FACP Physician N.C. Chapter of the American College of Physicians
Jessica Triche, MD Physician N.C. Academy of Family Physicians
Tracy Furgiuele, BSPh Pharmacist Research-Based Pharmaceutical Company 
Lawrence Greenblatt, MD Physician N.C. Physician Advisory Group Pharmacy and Therapeutics Committee